<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101461858</journal-id>
<journal-id journal-id-type="pubmed-jr-id">35583</journal-id>
<journal-id journal-id-type="nlm-ta">Autism Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Autism Res</journal-id>
<journal-title-group>
<journal-title>Autism research : official journal of the International Society for Autism Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">1939-3792</issn>
<issn pub-type="epub">1939-3806</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30883046</article-id>
<article-id pub-id-type="pmc">6546514</article-id>
<article-id pub-id-type="doi">10.1002/aur.2092</article-id>
<article-id pub-id-type="manuscript">NIHMS1015958</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Newborn Vitamin D Levels in Relation to Autism Spectrum Disorders and
Intellectual Disability: a Case-Control Study in California</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Windham</surname>
<given-names>Gayle C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pearl</surname>
<given-names>Michelle</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anderson</surname>
<given-names>Meredith C.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Poon</surname>
<given-names>Victor</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eyles</surname>
<given-names>Darryl</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jones</surname>
<given-names>Karen L.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lyall</surname>
<given-names>Kristen</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kharrazi</surname>
<given-names>Martin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Croen</surname>
<given-names>Lisa A.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>California Department of Public Health, Environmental
Health Investigations Branch, Richmond, CA</aff>
<aff id="A2"><label>2</label>Sequoia Foundation, La Jolla, CA</aff>
<aff id="A3"><label>3</label>Queensland Brain Institute, University of Queensland,
Brisbane, Australia</aff>
<aff id="A4"><label>4</label>Division of Rheumatology, Allergy and Clinical Immunology,
University of California, Davis Davis, CA</aff>
<aff id="A5"><label>5</label>A.J. Drexel Autism Institute, Drexel University,
Philadelphia, PA</aff>
<aff id="A6"><label>6</label>Kaiser Permanente Division of Research, Oakland, CA</aff>
<author-notes>
<corresp id="CR1">Corresponding author is Gayle C. Windham, Environmental Health
Investigations Branch/CDPH, 850 Marina Bay Parkway, Richmond, CA 94804,
<email>gayle.windham@cdph.ca.gov</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2020</year>
</pub-date>
<volume>12</volume>
<issue>6</issue>
<fpage>989</fpage>
<lpage>998</lpage>
<!--elocation-id from pubmed: 10.1002/aur.2092-->
<abstract id="ABS1">
<p id="P1">Vitamin D deficiency has been increasing concurrently with prevalence of
autism spectrum disorders (ASD), and emerging evidence suggests vitamin D is
involved in brain development. Most prior studies of ASD examined vitamin D
levels in children already diagnosed, but a few examined levels during perinatal
development, the more likely susceptibility period. Therefore, we examined
newborn vitamin D levels in a case-control study conducted among births in
2000–2003 in southern California. Children with ASD (N=563) or
Intellectual Disability (ID) (N=190) were identified from the Department of
Developmental Services and compared to population controls (N=436) identified
from birth certificates. 25-hydroxyvitamin D (25(OH)D) was measured in archived
newborn dried blood spots by a sensitive assay, and corrected to sera
equivalents. We categorized 25(OH)D levels as deficient (&lt;50nmol/L),
insufficient (50–74 nmol/L), and sufficient (≥75 nmol/L), and also
examined continuous levels, using logistic regression. The adjusted odds ratios
(AOR) and 95% confidence intervals (CI) for ASD were 0.96 (0.64–1.4) for
25(OH)D deficiency (14% of newborns) and 1.2 (0.86–1.6) for insufficiency
(26% of newborns). The AORs for continuous 25(OH)D (per 25nmol/L) were 1.0
(0.91–1.09) for ASD and 1.14 (1.0–1.30) for ID. Thus, in this
relatively large study of measured newborn vitamin D levels, our results do not
support the hypothesis of lower 25(OH)D being associated with higher risk of ASD
(or ID), although we observed suggestion of interactions with sex and
race/ethnicity. 25(OH)D levels were relatively high (median 84 nmol/L in
controls) so results may differ in populations with higher prevalence of low
vitamin D levels.</p>
</abstract>
<abstract abstract-type="summary">
<p id="P2">Lay Summary:</p>
<p id="P3">We studied whether vitamin D levels measured at birth were related to
whether a child later developed autism (or low IQ). Our results did not show
that children with autism, or low IQ, overall had lower vitamin D levels at
birth than children without autism. Vitamin D levels were fairly high, on
average, in these children born in Southern California.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>ASD</kwd>
<kwd>vitamin D</kwd>
<kwd>intellectual disability</kwd>
<kwd>hydroxy-vitamin D</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>